Shanrong Biotechnology Corp. (SRBT)
USD 0.1
(0.0%)
USD 0.1
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Total Assets | 1895.00 | 18.29 Thousand | - | - | - | - |
| Total Current Assets | 1895.00 | 18.29 Thousand | - | - | - | - |
| Cash And Short Term Investments | 1895.00 | 18.29 Thousand | - | - | - | - |
| Cash and Cash Equivalents | 1895.00 | 18.29 Thousand | - | - | - | - |
| Short Term Investments | - | - | - | - | - | - |
| Net Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other Current Assets | - | - | - | - | - | - |
| Total Non-Current Assets | - | - | - | - | - | - |
| Net PPE | - | - | - | - | - | - |
| Good Will And Intangible Assets | - | - | - | - | - | - |
| Good Will | - | - | - | - | - | - |
| Intangible Assets | - | - | - | - | - | - |
| Long-Term Investments | - | - | - | - | - | - |
| Tax Assets | - | - | - | - | - | - |
| Other Non Current Assets | - | - | - | - | - | - |
| Other Assets | - | - | - | - | - | - |
| Total Liabilities | 662.15 Thousand | 97.28 Thousand | - | - | - | - |
| Total Current Liabilities | 27.17 Thousand | 1816.00 | - | - | - | - |
| Account Payables | - | - | - | - | - | - |
| Tax Payables | - | - | - | - | - | - |
| Short Term Debt | - | - | - | - | - | - |
| Deferred Revenue | - | - | - | - | - | - |
| Other Current Liabilities | 27.17 Thousand | 1816.00 | - | - | - | - |
| Total Non Current Liabilities | 634.98 Thousand | 95.46 Thousand | - | - | - | - |
| Long-Term Debt | - | - | - | - | - | - |
| Deferred Revenue Non Current | - | - | - | - | - | - |
| Deferred Tax Liabilities Non Current | - | - | - | - | - | - |
| Other Non Current Liabilities | 634.98 Thousand | 95.46 Thousand | - | - | - | - |
| Other Liabilities | - | - | - | - | - | - |
| Total Equity | -660.26 Thousand | -76.98 Thousand | 2985.00 | 2985.00 | 2985.00 | 2985.00 |
| Stock Holders Equity | -660.26 Thousand | -76.98 Thousand | 2985.00 | 2985.00 | 2985.00 | 2985.00 |
| Common Stock | 485.00 | 485.00 | 2985.00 | 2985.00 | 2985.00 | 2985.00 |
| Retained Earnings | -11.08 Million | -6.17 Million | -6.17 Million | -6.17 Million | -6.17 Million | -6.17 Million |
| Accumulated other comprehensive income | - | -76.98 Thousand | 6.17 Million | 6.17 Million | 6.17 Million | 6.17 Million |
| Common Stock Equity | -660.26 Thousand | -76.98 Thousand | 2985.00 | 2985.00 | 2985.00 | 2985.00 |
| Capital Lease Obligation | - | - | - | - | - | - |
| Total Investments | - | - | - | - | - | - |
| Total Debt | - | - | - | - | - | - |
| Net Debt | -1895.00 | -18.29 Thousand | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Total Assets | 1597.00 | 1895.00 | 1895.00 | 1895.00 | 1804.00 | 1804.00 |
| Total Current Assets | 1597.00 | 1895.00 | 1895.00 | 1895.00 | 1804.00 | 1804.00 |
| Cash And Short Term Investments | 1597.00 | 1895.00 | 1895.00 | 1895.00 | 1804.00 | 1804.00 |
| Cash and Cash Equivalents | 1597.00 | 1895.00 | 1895.00 | 1895.00 | 1804.00 | 1804.00 |
| Short Term Investments | - | - | - | - | - | - |
| Net Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other Current Assets | - | - | - | - | - | - |
| Total Non-Current Assets | - | - | - | - | - | - |
| Net PPE | - | - | - | - | - | - |
| Good Will And Intangible Assets | - | - | - | - | - | - |
| Good Will | - | - | - | - | - | - |
| Intangible Assets | - | - | - | - | - | - |
| Long-Term Investments | - | - | - | - | - | - |
| Tax Assets | - | - | - | - | - | - |
| Other Non Current Assets | - | - | - | - | - | - |
| Other Assets | - | - | - | - | - | - |
| Total Liabilities | 677.83 Thousand | 672.83 Thousand | 662.15 Thousand | 662.15 Thousand | 109.28 Thousand | 104.28 Thousand |
| Total Current Liabilities | 42.84 Thousand | 37.84 Thousand | 27.17 Thousand | 27.17 Thousand | 1816.00 | 1816.00 |
| Account Payables | - | - | - | - | - | - |
| Tax Payables | - | - | - | - | - | - |
| Short Term Debt | - | - | - | - | - | - |
| Deferred Revenue | - | - | - | - | - | - |
| Other Current Liabilities | 42.84 Thousand | 37.84 Thousand | 27.17 Thousand | 27.17 Thousand | 1816.00 | 1816.00 |
| Total Non Current Liabilities | 634.98 Thousand | 634.98 Thousand | 634.98 Thousand | 634.98 Thousand | 107.46 Thousand | 102.46 Thousand |
| Long-Term Debt | - | - | - | - | - | - |
| Deferred Revenue Non Current | - | - | - | - | - | - |
| Deferred Tax Liabilities Non Current | - | - | - | - | - | - |
| Other Non Current Liabilities | 634.98 Thousand | 634.98 Thousand | 634.98 Thousand | 634.98 Thousand | 107.46 Thousand | 102.46 Thousand |
| Other Liabilities | - | - | - | - | - | - |
| Total Equity | -676.23 Thousand | -670.93 Thousand | -660.26 Thousand | -660.26 Thousand | -105.47 Thousand | -100.47 Thousand |
| Stock Holders Equity | -676.23 Thousand | -670.93 Thousand | -660.26 Thousand | -660.26 Thousand | -105.47 Thousand | -100.47 Thousand |
| Common Stock | 485.00 | 485.00 | 485.00 | 485.00 | 485.00 | 485.00 |
| Retained Earnings | -11.09 Million | -11.09 Million | -11.08 Million | -11.08 Million | -6.27 Million | -6.27 Million |
| Accumulated other comprehensive income | - | - | - | - | 6.17 Million | 6.17 Million |
| Common Stock Equity | -676.23 Thousand | -670.93 Thousand | -660.26 Thousand | -660.26 Thousand | -105.47 Thousand | -100.47 Thousand |
| Capital Lease Obligation | - | - | - | - | - | - |
| Total Investments | - | - | - | - | - | - |
| Total Debt | - | - | - | - | - | - |
| Net Debt | -1597.00 | -1895.00 | -1895.00 | -1895.00 | -1804.00 | -1804.00 |
0571
INTUCH
5604
CRTO
BIOGY
ANSC